Chinook Therapeutics Inc Cvr (ADRO)

Operating Expenses

$87.22M

TTM · Period ending: · USD

ADRO logo

ADRO Operating Expenses

Latest reported$87.22M
ADRO TTM Operating Expenses ($38.34M → $87.22M)
High-resolution chart · PNG

ADRO operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Chinook Therapeutics Inc Cvr Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
87,221,000
92,858,000
97,325,000
102,394,000
104,946,000
108,583,000
111,982,000
112,455,000
117,520,000
122,609,000
124,036,000
123,693,000
120,879,000
115,562,000
121,463,000
122,544,000
125,076,000
116,057,000
99,750,000
86,543,000
62,830,000
51,646,000
38,344,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.